WS #13487

19:12→19:41 UTC

From 500 msgs · 8 key-dev

Eli Lilly reported Q2 revenue +48% to $22.97B and EPS $8.38 vs $6.01 est., raised FY guidance, and CNBC raised PT to $1,300.

Eli Lilly beat-and-raise

Eli Lilly reported Q2 revenue +48% to $22.97B and EPS $8.38 vs $6.01 est., raised FY guidance, and CNBC raised PT to $1,300.